{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:47:51Z","timestamp":1764510471946,"version":"build-2065373602"},"reference-count":75,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T00:00:00Z","timestamp":1385596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The combination of genetic modification and hematopoietic stem cell (HSC) transplantation may provide the necessary means to develop an alternative treatment option to conventional antiretroviral therapy. As HSCs give rise to all hematopoietic cell types susceptible to HIV infection, modification of HSCs is an ideal strategy for the development of infection-resistant immune cell populations. Although promising results have been obtained in multiple animal models, additional evidence is needed to convincingly demonstrate the feasibility of this approach as a treatment of HIV-1 infected patients. Here, we review the potential of HSC transplantation and the recently identified limitations of this approach. Using the Berlin Patient as a model for a functional cure, we contrast the confines of autologous versus allogeneic transplantation. Finally, we suggest that although autologous, gene-modified HSC-transplantation may significantly reduce plasma viremia, reaching the lower detection limits currently obtainable through daily HAART will remain a challenging endeavor that will require innovative combinatorial therapies.<\/jats:p>","DOI":"10.3390\/v5122946","type":"journal-article","created":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T12:06:47Z","timestamp":1385640407000},"page":"2946-2962","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genetic Modification of Hematopoietic Stem Cells as a Therapy for HIV\/AIDS"],"prefix":"10.3390","volume":"5","author":[{"given":"Patrick","family":"Younan","sequence":"first","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA  98109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Kowalski","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA  98109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Kiem","sequence":"additional","affiliation":[{"name":"Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA  98109, USA"},{"name":"Department of Medicine, University of Washington, Seattle, WA  98195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2013,11,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/505147","article-title":"The survival benefits of AIDS treatment in the United States","volume":"194","author":"Walensky","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7326\/0003-4819-155-4-201108160-00358","article-title":"Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: a cohort analysis from Uganda","volume":"155","author":"Mills","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.immuni.2012.08.010","article-title":"Redefining the viral reservoirs that prevent HIV-1 eradication (Review)","volume":"37","author":"Eisele","year":"2012","journal-title":"Immunity"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia","volume":"278","author":"Wong","year":"1997","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","article-title":"Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy","volume":"94","author":"Chun","year":"1997","journal-title":"PNAS"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.stem.2011.12.015","article-title":"Hematopoietic-stem-cell-based gene therapy for HIV disease (Review)","volume":"10","author":"Kiem","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the cure of HIV infection by CCR5\u039432\/\u039432 stem cell transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QAD.0b013e328340fe28","article-title":"Allogeneic transplantation of CCR5-deficient progenitor cells in a patient with HIV infection: an update after 3 years and the search for patient no. 2","volume":"25","author":"Hutter","year":"2011","journal-title":"AIDS"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e1003347","DOI":"10.1371\/journal.ppat.1003347","article-title":"Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient","volume":"9","author":"Yukl","year":"2013","journal-title":"PLoS Pathogens"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hoxie, J.A., and June, C.H. (2012). Novel cell and gene therapies for HIV (Review). Cold Spring Harbor Perspectives in Medicine, 2.","DOI":"10.1101\/cshperspect.a007179"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.coi.2012.08.013","article-title":"Creating genetic resistance to HIV (Review)","volume":"24","author":"Burnett","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2249.2010.04312.x","article-title":"Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years (Review)","volume":"163","author":"Hutter","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1089\/aid.2006.0071","article-title":"Short communication: Immune reconstitution after autologous peripheral blood stem cell transplantation in HIV-infected patients: might be better than expected?","volume":"23","author":"Resino","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref_16","first-page":"430","article-title":"Gene therapy clinical trials for HIV (Review)","volume":"1","author":"Statham","year":"1999","journal-title":"Current Opinion in Molecular Therapeutics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1086\/652866","article-title":"Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma","volume":"50","author":"Simonelli","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nbt.1663","article-title":"Human hematopoietic stem\/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo","volume":"28","author":"Holt","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e12357","DOI":"10.1371\/journal.pone.0012357","article-title":"Survival of the fittest: positive selection of CD4+ T cells expressing a membrane-bound fusion inhibitor following HIV-1 infection","volume":"5","author":"Kimpel","year":"2010","journal-title":"PLoS ONE"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.1128\/JVI.06300-11","article-title":"Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector","volume":"86","author":"Walker","year":"2012","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood-2013-01-482224","article-title":"Positive selection of mC46-expressing CD4+ T cells and maintenance of virus specific immunity in a primate AIDS model","volume":"122","author":"Younan","year":"2013","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM198309153091114","article-title":"Bone marrow transplantation in AIDS","volume":"309","author":"Hassett","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM198410253111706","article-title":"Partial immune reconstitution in a patient with the acquired immunodeficiency syndrome","volume":"311","author":"Lane","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.3324\/haematol.11394","article-title":"First case of successful allogeneic stem cell transplantation in an HIV-patient who acquired severe aplastic anemia","volume":"92","author":"Wolf","year":"2007","journal-title":"Haematologica"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/QAD.0b013e3280b01836","article-title":"Failure of bone marrow transplantation to eradicate HIV reservoir despite efficient HAART","volume":"21","author":"Mahlaoui","year":"2007","journal-title":"AIDS"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/infdis\/jit086","article-title":"Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation","volume":"207","author":"Henrich","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/QAI.0b013e31828e6163","article-title":"Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphoma","volume":"63","author":"Cillo","year":"2013","journal-title":"J Acquir. Immune Defic. Syndr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/sj.bmt.1705028","article-title":"Unrelated cord blood transplantation for a human immunodeficiency virus-1-seropositive patient with acute lymphoblastic leukemia","volume":"36","author":"Tomonari","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1182\/blood.V99.2.698","article-title":"Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome","volume":"99","author":"Kang","year":"2002","journal-title":"Blood"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"393698","DOI":"10.4061\/2011\/393698","article-title":"Phase I\/II clinical trials using gene-modified adult hematopoietic stem cells for HIV: lessons learnt","volume":"2011","author":"Mitsuyasu","year":"2011","journal-title":"Stem Cells International"},{"key":"ref_31","first-page":"255","article-title":"Nonhuman primate models in AIDS research","volume":"8","author":"Evans","year":"2013","journal-title":"Current Opinion in HIV and AIDS"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.exphem.2004.12.008","article-title":"HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation","volume":"33","author":"Serrano","year":"2005","journal-title":"Exp. Hematol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1182\/blood.V98.13.3857","article-title":"Autologous stem cell transplantation for HIV-associated lymphoma","volume":"98","author":"Krishnan","year":"2001","journal-title":"Blood"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2004-04-1532","article-title":"Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas","volume":"105","author":"Krishnan","year":"2005","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev.immunol.18.1.529","article-title":"The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection (Review)","volume":"18","author":"Haynes","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/83381","article-title":"Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis","volume":"7","author":"Napolitano","year":"2001","journal-title":"Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"10319","DOI":"10.1128\/JVI.75.21.10319-10325.2001","article-title":"Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals","volume":"75","author":"Llano","year":"2001","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1097\/01.aids.0000189848.75699.0f","article-title":"Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients","volume":"19","author":"Rethi","year":"2005","journal-title":"AIDS"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/80868","article-title":"Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo","volume":"1","author":"Schluns","year":"2000","journal-title":"Nat. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"670957","DOI":"10.1155\/2012\/670957","article-title":"Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions (Review)","volume":"2012","author":"Gaardbo","year":"2012","journal-title":"Clinical & Developmental Immunology"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0092-8674(00)80291-3","article-title":"Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice","volume":"89","author":"Akashi","year":"1997","journal-title":"Cell"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1084\/jem.189.3.563","article-title":"The common cytokine receptor gamma chain and the pre-T cell receptor provide independent but critically overlapping signals in early alpha\/beta T cell development","volume":"189","author":"Aifantis","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1074-7613(00)80052-7","article-title":"Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors","volume":"10","author":"Pallard","year":"1999","journal-title":"Immunity"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/nm1295-1284","article-title":"In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency","volume":"1","author":"Chun","year":"1995","journal-title":"Nat. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/387183a0","article-title":"Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection","volume":"387","author":"Chun","year":"1997","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1165706","article-title":"The challenge of finding a cure for HIV infection (Review)","volume":"323","author":"Richman","year":"2009","journal-title":"Science"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/71577","article-title":"The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy","volume":"6","author":"Ramratnam","year":"2000","journal-title":"Nat. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJM199905273402101","article-title":"Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy","volume":"340","author":"Zhang","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.280.5371.1866","article-title":"Toward HIV eradication or remission: the tasks ahead","volume":"280","author":"Ho","year":"1998","journal-title":"Science"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.1117729","article-title":"A clonogenic bone marrow progenitor specific for macrophages and dendritic cells","volume":"311","author":"Fogg","year":"2006","journal-title":"Science"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1126\/science.1170540","article-title":"In vivo analysis of dendritic cell development and homeostasis","volume":"324","author":"Liu","year":"2009","journal-title":"Science"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1126\/science.1219179","article-title":"A lineage of myeloid cells independent of Myb and hematopoietic stem cells","volume":"336","author":"Schulz","year":"2012","journal-title":"Science"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-3806(99)00113-3","article-title":"Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain","volume":"Dev. Brain Res. 117","author":"Alliot","year":"1999","journal-title":"Brain Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4077","DOI":"10.1182\/blood-2007-02-073841","article-title":"Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages","volume":"110","author":"Klein","year":"2007","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1084\/jem.20091586","article-title":"Langerhans cell (LC) proliferation mediates neonatal development, homeostasis, and inflammation-associated expansion of the epidermal LC network","volume":"206","author":"Chorro","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ni852","article-title":"Langerhans cells renew in the skin throughout life under steady-state conditions","volume":"3","author":"Merad","year":"2002","journal-title":"Nat. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/nn2014","article-title":"Local self-renewal can sustain CNS microglia maintenance and function throughout adult life","volume":"10","author":"Ajami","year":"2007","journal-title":"Nature Neuroscience"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","article-title":"Fate mapping analysis reveals that adult microglia derive from primitive macrophages","volume":"330","author":"Ginhoux","year":"2010","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1086\/374786","article-title":"T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy","volume":"187","author":"Hunt","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/nm1511","article-title":"Microbial translocation is a cause of systemic immune activation in chronic HIV infection","volume":"12","author":"Brenchley","year":"2006","journal-title":"Nat. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1086\/590112","article-title":"Collagen deposition limits immune reconstitution in the gut","volume":"198","author":"Estes","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/01.aids.0000194801.51422.03","article-title":"Amount of lymphatic tissue fibrosis in HIV infection predicts magnitude of HAART-associated change in peripheral CD4 cell count","volume":"19","author":"Schacker","year":"2005","journal-title":"AIDS"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1073\/pnas.98.2.597","article-title":"Reduction in CD8+ cell noncytotoxic anti-HIV activity in individuals receiving highly active antiretroviral therapy during primary infection","volume":"98","author":"Stranford","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1128\/JVI.06000-11","article-title":"Antiretroviral therapy reduces the magnitude and T cell receptor repertoire diversity of HIV-specific T cell responses without changing T cell clonotype dominance","volume":"86","author":"Conrad","year":"2012","journal-title":"J. Virol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/COH.0b013e3283454058","article-title":"HIV-specific CD4 T cells and immune control of viral replication (Review)","volume":"6","author":"Porichis","year":"2011","journal-title":"Current Opinion in HIV & AIDS"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cell.2009.06.036","article-title":"Redefining chronic viral infection (Review)","volume":"138","author":"Virgin","year":"2009","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nature08511","article-title":"CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help","volume":"462","author":"Nakanishi","year":"2009","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"869505","DOI":"10.1155\/2012\/869505","article-title":"Characteristics of plasmacytoid dendritic cell and CD4+ T cell in HIV elite controllers (Review)","volume":"2012","author":"Herbeuval","year":"2012","journal-title":"Clinical & Developmental Immunology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/vim.2008.0025","article-title":"Decreased levels of circulating IL-21 in HIV-infected AIDS patients: correlation with CD4+ T-cell counts","volume":"21","author":"Iannello","year":"2008","journal-title":"Viral Immunology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4049\/jimmunol.0901967","article-title":"Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study","volume":"184","author":"Iannello","year":"2010","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4049\/jimmunol.0903915","article-title":"HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control","volume":"185","author":"Yue","year":"2010","journal-title":"J. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"481314","DOI":"10.1155\/2013\/481314","article-title":"HIV-1 genetic variability and clinical implications","volume":"2013","author":"Santoro","year":"2013","journal-title":"ISRN Microbiology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fimmu.2013.00052","article-title":"Do HIV-specific CTL continue to have an antiviral function during antiretroviral therapy? If not, why not, and what can be done about it?","volume":"4","author":"McIlroy","year":"2013","journal-title":"Frontiers in Immunology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1128\/JVI.00093-06","article-title":"Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses","volume":"80","author":"Deeks","year":"2006","journal-title":"J. Virol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature10237","article-title":"HIV-1 adaptation to NK-cell-mediated immune pressure","volume":"476","author":"Alter","year":"2011","journal-title":"Nature"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/5\/12\/2946\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:50:57Z","timestamp":1760219457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/5\/12\/2946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,28]]},"references-count":75,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12]]}},"alternative-id":["v5122946"],"URL":"https:\/\/doi.org\/10.3390\/v5122946","relation":{},"ISSN":["1999-4915"],"issn-type":[{"type":"electronic","value":"1999-4915"}],"subject":[],"published":{"date-parts":[[2013,11,28]]}}}